CLINICAL AI RISK CHECK

Could your clinic show that its AI use is governed, evidenced and under control?

Private GP, dental and specialist clinics are already using ambient scribes, ChatGPT, Copilot, transcription tools and AI-enabled platforms. This short check gives you an advisory view of whether one AI use case looks lower priority, control-dependent or in need of priority governance review.

Start the risk check Book AI Exposure Call

This tool provides an advisory governance risk indicator only. It is not legal advice, CQC certification, ICO approval, insurer coverage advice, MDO indemnity advice or clinical safety case sign-off.

Designed for one AI use case at a time

No patient data required

Around 2 minutes

Advisory indicator only

Built for private healthcare clinics

Private GP clinicsDental practicesSpecialist clinicsAmbient scribe teams

Why this matters

The risk is not AI use. The risk is having no documented position.

Most clinics do not start with a clean AI programme. They start with informal adoption: an ambient scribe in consultation, ChatGPT for drafting, Copilot for admin, transcription tools in meetings, and AI-enabled platforms introduced by suppliers. The governance risk is having no documented position when a patient, DPO, insurer, MDO, CQC inspector, commissioner or board asks how that AI use is controlled.

Interactive check

Your AI Governance Exposure Signal

Select the option that best reflects one AI use case in your clinic — for example an ambient scribe, ChatGPT or Copilot use, AI transcription, imaging AI, patient messaging automation or admin workflow automation.

1.AI use case type

2.Patient data exposure

3.Human review before use

4.Vendor and data evidence

5.DPIA and privacy evidence

6.Governance status

Governance signal

Lower advisory risk signal

GREEN · 6 / 31

LowerControl-dependentPriority review

Advisory risk indicator · 6 / 31

Lower advisory risk signal

Your selections suggest a lower immediate governance priority, provided the stated controls are accurate and evidenced. This is not approval or assurance. It means the use case appears more manageable if the register, policy, access controls and staff guidance are in place.

Recommended next actions

1Add or confirm the tool in the internal AI tool register.
2Record the approved use case, owner and review date.
3Confirm staff understand what data can and cannot be entered.
4Keep routine access review, training and vendor evidence current.

Still need a documented position? Book AI Exposure Call.

Important note

This tool provides an advisory governance risk indicator only. It is not legal advice, CQC certification, ICO approval, insurer coverage advice, MDO indemnity advice, clinical safety case sign-off or medical-device classification advice. Final decisions remain with the clinic’s accountable officers and advisers.

Boundary

What this quick check cannot show you

A short online check cannot discover shadow AI, inspect vendor contracts, confirm DPIA status, review patient transparency wording or evidence how clinicians are using tools in practice. That is why ELSA AI starts with the Clinical AI Exposure Diagnostic™.

Discover

Declared and suspected AI use across clinical, admin, marketing and operational workflows.

Evidence

DPIA readiness, vendor data position, human oversight, patient transparency and clinical safety indicators.

Decide

A board-readable RAG exposure map and 30-day priority action plan.

Govern

A pathway into policy, register, risk register, staff guidance, patient wording and evidence pack.

Clinical AI Exposure Diagnostic™

Need more than a risk signal?

In four working days from completed intake, the Clinical AI Exposure Diagnostic™ gives your clinic a documented view of what AI is in use, what patient data may be involved, what evidence is missing and what should be prioritised next.

Clinical AI Exposure Diagnostic™: £4,500 to £6,500 + VAT, depending on scope.

Book AI Exposure Call View Diagnostic deliverables

ELSA AI provides advisory governance support only. Final decisions on legal interpretation, DPIA sign-off, clinical safety documentation, insurer notification, MDO disclosure, regulatory engagement and risk acceptance remain with the client’s accountable officers and advisers.